首站-论文投稿智能助手
典型文献
Modulating microRNAs in cancer: next-generation therapies
文献摘要:
MicroRNAs (miRNAs) are a class of endogenously expressed non-coding regulators of the genome with an ability to mediate a variety of biological and pathological processes. There is growing evidence demonstrating frequent dysregulation of microRNAs in cancer cells, which is associated with tumor initiation, development, migration, invasion, resisting cell death, and drug resistance. Studies have shown that modulation of these small RNAs is a novel and promising therapeutic tool in the treatment of a variety of diseases, especially cancer, due to their broad influence on multiple cellular processes. However, suboptimal delivery of the appropriate miRNA to the cancer sites, quick degradation by nucleases in the blood circulation, and off target effects have limited their research and clinical applications. Therefore, there is a pressing need to improve the therapeutic efficacy of miRNA modulators, while at the same time reducing their toxicities. Several delivery vehicles for miRNA modulators have been shown to be effective in vitro and in vivo. In this review, we will discuss the role and importance of miRNAs in cancer and provide perspectives on currently available carriers for miRNA modulation. We will also summarize the challenges and prospects for the clinical translation of miRNA-based therapeutic strategies.
文献关键词:
作者姓名:
Nahid Arghiani;Khalid Shah
作者机构:
Center for Stem Cell and Translational Immunotherapy(CSTI),Harvard Medical School,Boston,MA 02115,USA;Department of Neurosurgery,Brigham and Women's Hospital,Harvard Medical School,Boston,MA 02115,USA;Harvard Stem Cell Institute,Harvard University,Cambridge,MA 02138,USA
引用格式:
[1]Nahid Arghiani;Khalid Shah-.Modulating microRNAs in cancer: next-generation therapies)[J].癌症生物学与医学(英文版),2022(03):289-304
A类:
B类:
Modulating,microRNAs,cancer,next,generation,therapies,MicroRNAs,miRNAs,are,class,endogenously,expressed,coding,regulators,genome,ability,mediate,variety,biological,pathological,processes,growing,evidence,demonstrating,frequent,dysregulation,cells,which,associated,tumor,initiation,development,migration,invasion,resisting,death,drug,resistance,Studies,have,shown,that,modulation,these,small,novel,promising,therapeutic,tool,treatment,diseases,especially,due,their,broad,influence,multiple,cellular,However,suboptimal,delivery,appropriate,sites,quick,degradation,by,nucleases,blood,circulation,off,target,effects,limited,research,clinical,applications,Therefore,there,pressing,need,improve,efficacy,modulators,while,same,reducing,toxicities,Several,vehicles,been,effective,vitro,vivo,In,this,review,will,discuss,role,importance,provide,perspectives,currently,available,carriers,We,also,summarize,challenges,prospects,translation,strategies
AB值:
0.672764
相似文献
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。